Brian Bossetta
Senior Writer, US Policy & Regulation
Brian holds a BA in history from Loyola University of New Orleans, is a die-hard Saints fan, and loves running, classical music and jazz. He lives with his wife, Caroline, in New York’s magnificent Hudson Valley.
Latest From Brian Bossetta
ITC Ruling Hands AliveCor Big Win Against Tech Giant
A judge with the US International Trade Commission sided with AliveCor in its ongoing feud with Apple, finding that the tech giant infringed on AliveCor’s patented electrocardiogram technology. The initial ruling sets up a full ITC review later this year.
Class I Recall For GE Healthcare CARESCAPE Ventilator
The US FDA has designated GE Healthcare’s recall of its CARESCAPE R860 ventilator as Class I, the agency’s most serious category.
Novel VR Treatment For Mental Illness Gets FDA Breakthrough
The US FDA has granted its breakthrough designation to a virtual reality therapy that recreates everyday scenarios for patients dealing with severe anxiety and schizophrenia.
Biden’s Biomedical Research Initiative Moves One Step Closer To Fruition
The US House of Representatives overwhelmingly passed legislation authorizing the creation of a federal health agency to advance biomedical research. The bill now goes to the Senate.
French Company Gets FDA Breakthrough Status For Brain Device
The US FDA has designated Carthera’s SonoCloud-9 as a breakthrough device. The French company’s ultrasound technology is designed to treat a wide range of brain diseases, including recurrent glioblastoma.
FDA Issues Final Guidance For Radiological Devices Using Quantitative Imaging
The US FDA has published its final guidance for premarket submissions of radiological devices that use quantitative imaging – technology which offers clinicians a more accurate picture of a disease.